Vancomycin pharmacokinetics in patients with peritonitis on peritoneal dialysis.
AUTOR(ES)
Magera, B E
RESUMO
Vancomycin pharmacokinetics were studied in four patients with peritonitis undergoing chronic intermittent peritoneal dialysis. Serum levels exceeding 4.0 micrograms/ml were maintained for 8 and 13 days after a single 1-g intravenous dose. Vancomycin serum concentrations measured before, during, and upon completion of dialysis revealed no appreciable decline. Peritoneal fluid concentrations in two patients exceeded 4.0 micrograms/ml for more than 12 days.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=184793Documentos Relacionados
- Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis.
- Staphylococcal peritonitis in patients on continuous peritoneal dialysis.
- Microbiological diagnosis of peritonitis in patients on continuous ambulatory peritoneal dialysis.
- Laboratory diagnosis of peritonitis in patients on continuous ambulatory peritoneal dialysis.
- Pseudomonas paucimobilis peritonitis in patients treated by peritoneal dialysis.
